strategic partnership

Mastering Clinical Trial Outsourcing: FSP Strategies from Industry Experts

2 minute read

Published: November 25th, 2024

In Partnership With PCMG

Phastar and PCMG partnered to start 2025 with an insightful fireside chat, sharing their industry-leading expertise on optimizing clinical trial outsourcing. The Pharmaceutical Contract Management Group (PCMG) is a membership association that unites and connects professionals working in clinical development outsourcing, procurement, and contract management.

In today’s dynamic pharmaceutical and biotech landscape the FSP model has emerged as a critical approach for optimizing operational efficiency, enhancing scalability, and driving innovation across clinical trials and development programs. This session explored the evolving role of FSPs in enabling organizations to focus on core competencies while leveraging specialized expertise for critical functions such as biostatistics, data management, and clinical operations.

Through an engaging and informative discussion, industry leaders shared insights on how the FSP model aligns with organizational goals, accelerates project timelines, and ensures regulatory compliance across regions. Key considerations, such as talent acquisition, strategic partnerships, and cost optimization, were also discussed to provide a comprehensive understanding of the FSP model’s impact on clinical development success. Watch the recording for a deep dive into how this model is reshaping the future of pharmaceutical and biotech operations.

Speakers:
•    Steve Martindill (Moderator), PCMG Clinical Outsourcing Community
•    Natalie Fforde
, Senior Vice President, Global Strategic Partnerships, Phastar
•    Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen
•    Elisa Mansfield
, Vice President, FSP, Phastar
•    Gill Slater, Chair
, PCMG Clinical Outsourcing Community

Learning Points:
•    Understanding the Strategic Value of FSPs: Explore how FSP models drive operational efficiency, innovation, and scalability, ensuring alignment with clinical development goals.
•    Customization of FSP Partnerships: Learn how to tailor FSP models to suit organizational size, project scope, and evolving needs, ensuring flexibility and adaptability.
•    Overcoming Common Partnership Challenges: Gain insight into resolving communication, operational, and scalability challenges through effective frameworks, transparency, and collaboration.
•    Leveraging Specialist Expertise: Understand how FSPs can offer deep therapeutic and operational expertise, optimizing key areas such as biostatistics, clinical operations, and data management.
•    Q&A Session: Ask the Experts.

Complete the form below to access the recording and slides.

Related articles

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

April 29th, 2025 1 minute read

Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulat...

3-Part Online Series: Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

3-Part Online Series: Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

April 8th, 2025 1 minute read

Join us for an insightful, 3-part online series to explore the latest innovations in early phase clinical trials, the...

3-Part Online Series: Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

3-Part Online Series: Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

April 8th, 2025 1 minute read

Join us for an insightful, 3-part online series to explore the latest innovations in early phase clinical trials, the...